AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18631346
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with grass pollen extract
Trial: 11910260
Drug: Imipramine maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine maintenance treatment
Trial: 8529326
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg oral dose
Trial: 8529326
Drug: Phenytoin 300
RxNorm normalized name: phenytoin 300 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin 300 mg oral dose
Trial: 274992
Drug: BCG administered
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG administered by the multiple-puncture technique
Trial: 8912488
Drug: Anticonvulsive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticonvulsive treatment with carbamazepine
Trial: 30106963
Drug: Dexmedetomidine supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine supplemented morphine analgesia
Trial: 29444530
Drug: Morphine analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine analgesia
Trial: 22526864
Drug: Inhaled salmeterol
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled salmeterol and transdermal tulobuterol patch
Trial: 20500876
Drug: 7.2% hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.2% hypertonic saline with 6% poly (O‐2‐hydroxyethyl) starch solution (HH)
Trial: 20500876
Drug: Standard fluid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fluid therapy (Ringer's Acetate and saline 9 mg/ml) (control)
Trial: 16339664
Drug: ICL670, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICL670, a once-daily oral iron chelator
Trial: 9165691
Drug: Intravenous proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous proton pump inhibitors (80 mg pantoprazole or omeprazole bolus followed by 8 mg/hour continuous infusion)
Trial: 1642186
Drug: Enalapril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (2.5 to 40 mg/day)
Trial: 23672109
Drug: Intravenous Paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Paracetamol 1g diluted to 20 mls with normal saline
Trial: 23672109
Drug: Intravenous normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous normal saline 20 mls
Trial: 19582757
Drug: General occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General occupational therapy (Control)
Trial: 10408031
Drug: Simvastatin (S)
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin (S) 40 mg daily
Trial: 3555578
Drug: Guanfacine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (2 mg once daily)
Trial: 25399229
Drug: Paclitaxel (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (175 mg/m(2))
Trial: 15747272
Drug: Rofecoxib, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib, 50 mg, 1 hour before surgery
Trial: 10371471
Drug: Intravenous gentamicin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous gentamicin, 5 mg/kg over 60 min, max dose 500 mg (Group I)
Trial: 6664154
Drug: Tilidine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine (100 mg)
Trial: 6852098
Drug: Tilidine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine (100 mg); Naloxone (32 mg)
Trial: 31703120
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (1 g/d)
Trial: 27844124
Drug: Multidisciplinary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary treatment program
Trial: 19437058
Drug: Soybean oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil (30 mL daily)
Trial: 14872552
Drug: Lescol IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lescol IR 40 mg twice a day for 7 days
Trial: 14872552
Drug: Lescol XL
RxNorm normalized name: Lescol XL
DrugBank: Fluvastatin (DB01095)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lescol XL 80 mg and 160 mg
Trial: 9839524
Drug: Soymilk-supplemented diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soymilk-supplemented diet (400 mL daily, containing about 109 mg of isoflavones)
Trial: 2398199
Drug: 0.5% POL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% POL (subgroup treatment for TM)
Trial: 22237162
Drug: APF gel
RxNorm normalized name: APF Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: APF gel (1.23% F) application for 1 min
Trial: 21569378
Drug: Atomoxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine treatment for ADHD
Trial: 11598848
Drug: 11-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11-valent pneumococcal conjugate vaccine with aluminum adjuvant
Trial: 11598848
Drug: 11-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11-valent pneumococcal conjugate vaccine without aluminum adjuvant
Trial: 8079927
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg twice daily for 30 days)
Trial: 2647007
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg enprofylline twice daily
Trial: 17206696
Drug: Lactobacillus johnsonii,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus johnsonii, LA1 (1010 CFU daily for 12 weeks)
Trial: 8310560
Drug: Combined radiation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined radiation, drug and estrogen treatments (II)
Trial: 8310560
Drug: Radiation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation treatment alone (I)
Trial: 8310560
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy alone (III)
Trial: 2426899
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing 0.030 mg ethinylestradiol (EE) plus 0.150 mg levonorgestrel
Trial: 2426899
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive containing 0.150 mg levonorgestrel
Trial: 31495419
Drug: Equine-assisted therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equine-assisted therapy
Trial: 17912998
Drug: Manual toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual toothbrush (Oral-B 35-MTB)
Trial: 10461824
Drug: Thalidomide 100
RxNorm normalized name: thalidomide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 100 mg
Trial: 12001058
Drug: Thalidomide 150
RxNorm normalized name: thalidomide 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 150 mg
Trial: 22133776
Drug: Thalidomide (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (all doses)
Trial: 386390
Drug: Viloxazine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viloxazine (300 mg/d)
Trial: 31923017
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of 2% lidocaine with 1:100,000 adrenaline
Trial: 31923017
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL of saline solution (control group)
Trial: 31437010
Drug: High-dose D.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose D. farinae Drops
Trial: 31437010
Drug: Medium-dose D.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose D. farinae Drops
Trial: 19197266
Drug: sibutramine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sibutramine plus lifestyle modification (combined therapy)
Trial: 15599313
Drug: basiliximab +
RxNorm normalized name: Basiliximab
DrugBank: Basiliximab (DB00074)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: basiliximab + steroids
Trial: 19779855
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (Control)
Trial: 27842543
Drug: Integrated care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated care centers providing core HIV services (HIV counseling and testing, education, condom distribution, needle exchange, opioid therapy, STI management, TB screening, ART)
Trial: 6997513
Drug: BCG treatment
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG treatment
Trial: 20618313
Drug: Magnesium Administration
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium Administration Rank (MAR)
Trial: 9250111
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of 1200 mg Ca/d
Trial: 9250111
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake of 1300 mg Ca/d
Trial: 3234410
Drug: Lidocaine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (100 mg bolus followed by 2 mg min‐1 infusion)
Trial: 3234410
Drug: Propafenone (105
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone (105 mg bolus followed by 300 mg orally every 8 h)
Trial: 27026482
Drug: Oral azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral azithromycin (one dose)
Trial: 17038453
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg twice daily for 10 days followed by placebo (placebo group)
Trial: 17038453
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg twice daily for 10 days followed by continued doxycycline 100 mg twice daily over 4 months (doxycycline group)
Trial: 11071595
Drug: Energy-enriched formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy-enriched formula (1.5 kcal/mL)
Trial: 8923869
Drug: Two 200‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two 200‐mg testosterone pellets (400 mg, 3 mg/day)
Trial: 8923869
Drug: Four 200‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four 200‐mg testosterone pellets (800 mg, 6 mg/day)
Trial: 8923869
Drug: Four 200‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four 200‐mg testosterone pellets (800 mg, 6 mg/day) plus a single im injection of 300 mg depot medroxyprogesterone acetate (DMPA)
Trial: 4018502
Drug: Morphine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (100 micrograms/kg body wt as a bolus intravenously)
Trial: 27237200
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and PDT (1% methylene blue solution)
Trial: 25121804
Drug: Acetaminophen ER
RxNorm normalized name: acetaminophen Extended Release Oral Tablet
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen ER 1300 mg three times daily
Trial: 22382344
Drug: Certolizumab and
RxNorm normalized name: CERTOLIZUMAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Certolizumab and golimumab (anti-TNF treatment)
Trial: 22382344
Drug: DMARD (nonbiological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMARD (nonbiological disease-modifying antirheumatic drug)
Trial: 12890127
Drug: Sumatriptan 50
RxNorm normalized name: sumatriptan 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 50 mg plus metoclopramide 10 mg
Trial: 12890127
Drug: Sumatriptan 50
RxNorm normalized name: sumatriptan 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 50 mg plus placebo
Trial: 1546723
Drug: 60-minute infusion/glycopyrrolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60-minute infusion/glycopyrrolate pretreatment
Trial: 19646081
Drug: Talipexole hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Talipexole hydrochloride tablets alone
Trial: 19646081
Drug: Talipexole hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Talipexole hydrochloride tablets with Madopar (co-beneldopa)
Trial: 17462549
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (100 mg intramuscularly for 3 months)
Trial: 17462549
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (optimally conventional treatment of CKD)
Trial: 14718433
Drug: Intranasal Moli1901
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal Moli1901
Trial: 12563960
Drug: Cefuroxime (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime (250 mg orally twice daily)
Trial: 6376951
Drug: Crystalline amino
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalline amino acid‐glucose (CAA‐G) diet
Trial: 6376951
Drug: Partially hydrolyzed
RxNorm normalized name: Human Skin Proteins, Partially Hydrolyzed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially hydrolyzed protein‐glucose (PHP‐G) diet
Trial: 31251694
Drug: Interval cytoreductive
RxNorm normalized name: Minerval
DrugBank: Idroxioleic acid (DB18213)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interval cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC)
Trial: 20858539
Drug: Acitretin loaded
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin loaded Nanostructured Lipid Carriers (ActNLCs) gel
Trial: 20858539
Drug: Act plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Act plain gel
Trial: 1501354
Drug: PAR3 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAR3 group (3 mL of MVI‐Pediatric supplement, parenterally fed)
Trial: 1501354
Drug: PAR2 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAR2 group (2 mL, parenterally fed)
Trial: 29111980
Drug: Metformin continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin continued group
Trial: 29111980
Drug: Metformin discontinued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin discontinued group
Trial: 25877422
Drug: Auto-crosslinked hyaluronic
RxNorm normalized name: hyaluronic acid, crosslinked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auto-crosslinked hyaluronic acid gel (3 ml)
Trial: 25877422
Drug: Auto-crosslinked hyaluronic
RxNorm normalized name: hyaluronic acid, crosslinked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auto-crosslinked hyaluronic acid gel
Trial: 21273897
Drug: Vibration treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibration treatment
Trial: 11925463
Drug: Daily supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplementation with 80 mg of zinc as zinc oxide plus 2 mg of copper as cupric oxide
Trial: 3540871
Drug: naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naproxen sodium 550 mg
Trial: 9620100
Drug: acetaminophen 325
RxNorm normalized name: acetaminophen 325 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acetaminophen 325 mg
Trial: 9620100
Drug: bromfenac 25
RxNorm normalized name: bromfenac 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromfenac 25 mg (fed)
Trial: 9620100
Drug: bromfenac 25
RxNorm normalized name: bromfenac 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromfenac 25 mg (fasted)
Trial: 2615927
Drug: Clomipramine, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine, 10 mg i.v.
Trial: 2615927
Drug: Desipramine, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine, 25 mg i.m.
Trial: 1687425
Drug: metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol 100 mg
Trial: 28145158
Drug: Sitagliptin (acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin (acute dosing)
Trial: 21696807
Drug: Doxazosin gastrointestinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin gastrointestinal therapeutic system (doxazosin-GITS) 4 mg
Trial: 10801250
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg
Trial: 19465881
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 to 20 mg/day
Trial: 10952418
Drug: Nonselective endothelin-1
RxNorm normalized name: nitric oxide synthase endothelial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonselective endothelin-1 inhibitors
Trial: 10952418
Drug: Selective endothelin
RxNorm normalized name: endothelial growth factor A, vascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective endothelin A receptor inhibitors
Trial: 10952418
Drug: Nonselective antagonism
RxNorm normalized name: ganirelix acetate Prefilled Syringe [Antagon]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonselective antagonism of endothelin receptors
Trial: 24924874
Drug: Increased awareness
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased awareness and acceptance of emotions and thoughts during treatment
Trial: 12588577
Drug: HCTZ 25
RxNorm normalized name: HCTZ 25 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ 25 mg
Trial: 2257857
Drug: Cicletanine 50
RxNorm normalized name: cicletanine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 50 mg
Trial: 3867354
Drug: Cicletanine 150
RxNorm normalized name: cicletanine
DrugBank: Cicletanine (DB12766)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 150 mg
Trial: 20578209
Drug: sotrastaurin 100
RxNorm normalized name: Sotrastaurin
DrugBank: Sotrastaurin (DB12369)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotrastaurin 100 mg
Trial: 20578209
Drug: cyclosporine 400
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cyclosporine 400 mg
Trial: 20578209
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sotrastaurin with 400 mg cyclosporine
Trial: 20578209
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sotrastaurin with 100 mg cyclosporine
Trial: 7767427
Drug: Physiologic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiologic saline followed by albuterol (PA group; n = 25)
Trial: 7767427
Drug: Intramuscular epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular epinephrine
Trial: 7028411
Drug: Cefuroxime 750
RxNorm normalized name: cefuroxime 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 750 mg, intramuscular injection, three times daily for 7-10 days
Trial: 7028411
Drug: Ampicillin 500
RxNorm normalized name: ampicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 500 mg, intramuscular injection, three times daily for 7-10 days
Trial: 25216508
Drug: Spinal cord
RxNorm normalized name: BOS TAURUS SPINAL CORD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal cord stimulation (SCS) in combination with best medical treatment (BMT)
Trial: 22893497
Drug: Best medical
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best medical treatment (BMT) only
Trial: 20120423
Drug: Dapsone gel
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dapsone gel 5% combined with adapalene gel 0.1%
Trial: 20120423
Drug: Dapsone gel
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dapsone gel 5% combined with benzoyl peroxide gel 4%
Trial: 20120423
Drug: Dapsone gel
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dapsone gel 5% combined with moisturizer
Trial: 8909483
Drug: Two-dose mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose mixed regimen (M at 2 months and T at 4 months)
Trial: 8909483
Drug: Two-dose mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose mixed regimen (MT-)
Trial: 6405772
Drug: Codeine 60
RxNorm normalized name: codeine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine 60 mg by mouth
Trial: 16167458
Drug: Antipsychotic polypharmacy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic polypharmacy (APP)
Trial: 26845273
Drug: Antipsychotic monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic monotherapy (APM)
Trial: 12490031
Drug: Simulated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simulated treatment